John Moriarty

John Moriarty

Director/Board Member at
American Kidney Fund, Inc.

Net worth: 704 814 $ as of 2026-09-29

58 year
Health Technology
Consumer Services
Health Services

Profile

John B. Moriarty is Secretary & Trustee at American Kidney Fund, Inc. since 2015 and Secretary & Chief Legal Officer at Kardigan, Inc. starting in 2026.
Former roles include Executive Director & Senior Counsel at Amgen, Inc. from 2002 to 2008; Chief Legal Officer & General Counsel at Elan Corp.
Plc from 2008 to 2012; Executive Vice President & General Counsel at Alexion Pharmaceuticals, Inc. from 2014 to 2018; Secretary, Executive VP & General Counsel at Portola Pharmaceuticals LLC from 2018 to 2020; Senior Vice President & General Counsel at Elan Pharmaceuticals LLC; Secretary, Chief Legal Officer & Executive VP at Olema Pharmaceuticals, Inc. from 2020 to 2023; Secretary, Chief Legal Officer & Executive VP at Mirati Therapeutics, Inc. from 2023 to 2024; and Secretary & Chief Legal Officer at Avidity Biosciences, Inc. from 2024 to 2026.
Education includes undergraduate studies at the University of Virginia and graduate studies at the University of Georgia School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.05%
2026-06-16 47,784 ( 0.05% ) 704 814 $ 2026-09-29

John Moriarty active positions

CompaniesPositionStart
Director/Board Member 2014-12-31

Former positions of John Moriarty

CompaniesPositionEnd
AVIDITY BIOSCIENCES, INC. General Counsel 2026-02-26
MIRATI THERAPEUTICS General Counsel 2024-01-22
OLEMA PHARMACEUTICALS, INC. General Counsel 2023-04-30
PORTOLA PHARMACEUTICALS, INC. General Counsel 2020-06-30
ALEXION PHARMACEUTICALS, INC. General Counsel 2018-01-31
See the detail of John Moriarty's experience

Education of John Moriarty

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

86

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Consumer Services

Health Technology